By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regeneron Pharmaceuticals, Inc. 

777 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-847-7000 Fax: n/a


SEARCH JOBS



Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.

Visit our website – www.regeneron.com
Check out our openings – http://careers.regeneron.com


Key Statistics


Email:
Ownership: Public

Web Site: Regeneron
Employees: 2300+
Symbol: REGN
 



Industry
Biotechnology


Collaborations

Sanofi US 

Bayer 

Geisinger Health System  Collaboration with Regeneron Genetics Center LLC, wholly-owned subsidiary of Regeneron.

Avalanche Biotech 





Company News
Regeneron (REGN), Cellectis (ALCLS), Flagship Ventures And Others Headline NewYorkBIO 2016 CEO Breakfast Club Series 2/8/2016 12:33:03 PM
Regeneron (REGN), Cellectis (ALCLS), Flagship Ventures And Others Headline NewYorkBIO 2016 CEO Breakfast Club Series 2/8/2016 7:30:31 AM
Regeneron (REGN) Stock Rocks, but Vertex (VRTX), Medivation (MDVN) & Jazz Pharma (JAZZ) Roll 2/3/2016 6:08:01 AM
Kymab Succeeds In Revoking Regeneron (REGN)’s UK VelocImmune Patents 2/2/2016 9:36:27 AM
As Eylea and Praluent Sales Take Off, Regeneron (REGN) Plans to Expand HQ and Manufacturing Sites 1/29/2016 6:57:30 AM
Regeneron (REGN) To Report Fourth Quarter And Full Year 2015 Financial And Operating Results And Host Conference Call And Webcast On February 9, 2016 1/26/2016 10:01:08 AM
Regeneron (REGN) And Sanofi (SNY) Announce Sarilumab Biologics License Application Accepted For Review By US FDA 1/8/2016 6:25:12 AM
Regeneron (REGN) Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference 1/7/2016 11:30:45 AM
Regeneron (REGN) Investors Get Jitters From False Praluent Data 1/7/2016 7:28:38 AM
Regeneron (REGN) Mourns Passing Of Dr. Alfred G. Gilman, Board Member And Nobel Laureate 12/28/2015 7:27:21 AM
12345678910...
//-->